跳至主要内容
临床试验/NCT04703881
NCT04703881已完成不适用

Tolerance and Acceptability Evaluation AYMES ActaGain

Aymes International Limited2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Gastro-Intestinal Tolerance when consuming AYMES ActaGain

研究概览

简要总结

To evaluate tolerance and acceptability of 'AYMES ActaGain' in patients requiring supplementary oral nutritional support compared with currently available alternatives.

详细描述

To evaluate tolerance and acceptability of 'AYMES ActaGain' in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference, convenience etc.

To obtain data to support an ACBS submissions for 'AYMES ActaGain' (to allow for prescription in the community at NHS expense).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients.
  • ≥ 18 years of age.
  • Patients of the intended target group (e.g. MUST score ≥ 1, with or at risk of disease related malnutrition) with an anticipated period of nutritional support ≥ 4 weeks.
  • Patient is able and willing to provide written informed consent.

排除标准

  • Patients with medical or dietary contraindication to any feed ingredients.
  • Patients requiring sole enteral tube feeding or parenteral nutrition.
  • Patients with chronic renal disease requiring dialysis.
  • Patients with liver failure.
  • Patients for whom the investigator has concerns regarding the ability or willingness of the patient and or carer to comply with protocol requirements.
  • Patients assessed by a Speech and Language Therapist who require thickened fluids.
  • Participation in any other studies that may interfere with this study.

结局指标

主要结局

Gastro-Intestinal Tolerance when consuming AYMES ActaGain

时间窗: 30 days

To assess gastro-intestinal tolerance of 'AYMES ActaGain' in patients in the community requiring oral nutritional supplementation. Monitoring includes recording the number of any GI complaints via a daily diary.

次要结局

  • Acceptability and Palatability of Consuming the Nutritional Supplement: questionnaire(30 days)
  • Compliance(30 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验